Literature DB >> 16451050

Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity.

Yasuhiro Goto1, Sachie Arai-Otsuki, Yukari Tachibana, Daisuke Ichikawa, Satoshi Ozaki, Hiroyuki Takahashi, Yoshikazu Iwasawa, Osamu Okamoto, Shoki Okuda, Hisashi Ohta, Takeshi Sagara.   

Abstract

A focused library approach identifying novel leads to develop a potent ORL1 antagonist is described. Beginning from a compound identified by random screening, an exploratory library that exhibited a diverse display of pharmacophores was designed. After evaluating ORL1 antagonistic activity, a highly focused library was designed based on 3D-pharmacophore similarity to known actives. A novel D-proline amide class was identified in this library and was found to possess potent ORL1 antagonistic activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451050     DOI: 10.1021/jm0509851

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.

Authors:  Nurulain T Zaveri
Journal:  J Med Chem       Date:  2016-03-14       Impact factor: 7.446

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.

Authors:  Aurelia Ces; David Reiss; Ondine Walter; Jürgen Wichmann; Eric P Prinssen; Brigitte L Kieffer; Abdel-Mouttalib Ouagazzal
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

Review 5.  Managing Parkinson's disease: moving ON with NOP.

Authors:  Daniela Mercatelli; Erwan Bezard; Roberto Eleopra; Nurulain T Zaveri; Michele Morari
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

6.  GPCR stabilization using the bicelle-like architecture of mixed sterol-detergent micelles.

Authors:  Aaron A Thompson; Jeffrey J Liu; Eugene Chun; Daniel Wacker; Huixian Wu; Vadim Cherezov; Raymond C Stevens
Journal:  Methods       Date:  2011-10-21       Impact factor: 3.608

7.  Modulation of silent and constitutively active nociceptin/orphanin FQ receptors by potent receptor antagonists and Na+ ions in rat sympathetic neurons.

Authors:  Saifeldin Mahmoud; Wojciech Margas; Claudio Trapella; Girolamo Caló; Victor Ruiz-Velasco
Journal:  Mol Pharmacol       Date:  2010-02-16       Impact factor: 4.436

Review 8.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

Review 9.  Grand opening of structure-guided design for novel opioids.

Authors:  Marta Filizola; Lakshmi A Devi
Journal:  Trends Pharmacol Sci       Date:  2012-11-03       Impact factor: 14.819

10.  The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor.

Authors:  Rebecca L Miller; Aaron A Thompson; Claudio Trapella; Remo Guerrini; Davide Malfacini; Nilkanth Patel; Gye Won Han; Vadim Cherezov; Girolamo Caló; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2015-10-29       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.